Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

CDXS Stock Forecast, Price Targets, Chart, Dividends & Analysis

Codexis Inc. logo

Codexis Inc.

Sector: Healthcare   

Industry: Biotechnology

2.24
 
USD
  
0.01
  
(0.45%)
Previous close: 2.23  Open: 2.26  Bid: 2.3  Ask: 2.33
52 week range    
1.90   
   6.08
Mkt Cap: 202 M  Avg Vol (90 Days): 971,645
Last updated: Tuesday 17th June 2025

Stock Rankings

38
MarketXLS Rank
60
Value
20
Technical
36
Quality
How are these ranks calculated?
Search for a stock

Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

CDXS Income Statement

Annual
Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
AcquiredInProcessRnD31 M
Amortization of intangibles3 M3 M3 M3 M3 M3 M
Basic EPS from continuing operations-0.21-0.4-0.33-0.51-1.12-0.89
Basic EPS total-0.21-0.4-0.33-0.51-1.12-0.89
Basic weighted shares outstanding39 M41 M46 M52 M57 M59 M65 M65 M68 M73 M
Cost of sales-7 M-10 M-14 M-13 M16 M14 M22 M38 M13 M16 M
Depreciation-1 M-1 M2 M2 M3 M5 M6 M5 M
DepreciationAndAmortization-1 M-1 M2 M2 M3 M5 M6 M5 M
Diluted EPS total-0.19-0.21-0.5-0.21-0.21-0.4-0.33-0.51-1.12-0.89
Diluted normalized net income/share-0.33-0.51-1.12-0.89
Diluted weighted shares outstanding40 M41 M46 M52 M57 M59 M65 M65 M68 M73 M
Earnings from equity interest26 M
EarningsFromEquityInterestNetOfTax26 M
GainOnSaleOfPPE-32000.042000.0
GainOnSaleOfSecurity25000.0-525000.0
GeneralAndAdministrativeExpense-3 M-3 M-3 M-3 M32 M35 M49 M52 M53 M55 M
Gross operating profit10 M8 M36 M48 M53 M55 M83 M101 M57 M43 M
ImpairmentOfCapitalAssets10 M165000.0
Income before tax-8 M-9 M-23 M-11 M-12 M-24 M-21 M-33 M-76 M-65 M
Income restructuring and M&A3 M3 M
Income taxes-338000.0-40000.081000.0-37000.017000.0339000.0189000.0276000.069000.034000.0
Interest income19000.060000.0147000.0671000.01 M405000.0459000.01 M4 M4 M
InterestExpenseNonOperating10000.01000.0
InterestIncomeOperating26 M31 M
MiscOtherSpecialCharges-92000.0-291000.0-656000.0-156000.01 M124000.0-12 M-10 M
Net income from total operations-8 M-9 M-23 M-11 M-12 M-24 M-21 M-34 M-76 M-65 M
NetIncomeCommonStockholders-8 M-9 M-23 M-11 M-12 M-24 M-21 M-34 M-76 M-65 M
NetIncomeContinuousOperations-8 M-9 M-23 M-11 M-12 M-24 M-21 M-34 M-76 M-65 M
NetNonOperatingInterestIncomeExpense19000.060000.0147000.0671000.01 M405000.0459000.01 M4 M4 M
Normalized income-58 M
Operating income-34 M-40 M-23 M-11 M-13 M-24 M-23 M-35 M-68 M-59 M
Operating income before depreciation (EBITDA)-3 M-4 M-22 M-10 M-7 M-19 M-17 M-23 M-66 M-58 M
OperatingExpense43 M-57 M-73 M59 M65 M79 M105 M132 M112 M101 M
Other income net25000.0-42000.092000.0291000.0656000.0156000.0-1 M-3 M12 M10 M
OtherGandA-3 M-3 M-3 M-3 M32 M35 M49 M52 M53 M55 M
OtherImpairmentOfCapitalAssets12 M7 M
OtherOperatingExpenses168000.094000.0-73 M-1 M-1 M-1 M-2 M-4 M-2 M-1 M
OtherWriteOff-7000.0-387000.0
PromotionAndAdvertising-300000.0-500000.0-700000.0-500000.0500000.0300000.0300000.0300000.0300000.0
RealizedCapitalGain31 M
RentAndLandingFees-3 M-3 M-3 M-3 M
Research & development expense21 M22 M30 M30 M34 M44 M56 M80 M59 M46 M
ResearchExpense21 M22 M30 M30 M34 M44 M56 M80 M59 M46 M
RestructringAndMnAIncome3 M3 M
Revenue per share3 M3 M3 M8 M7 M6 M
SalariesAndWages-5 M-6 M-7 M-8 M7 M8 M12 M15 M10 M13 M
Selling Gen & administrative expense22 M25 M29 M29 M32 M35 M49 M52 M53 M55 M
SellingAndMarketingExpense22 M25 M29 M29 M500000.0300000.0300000.0300000.0300000.0
SellingExpense22 M25 M29 M29 M
Special income/charges31 M-3 M-13 M-165000.0
Total Income available for interest expense (EBIT)-8 M-9 M-23 M-11 M-12 M-24 M-23 M-33 M-76 M-65 M
Total common shares outstanding40 M41 M48 M54 M59 M64 M65 M66 M70 M83 M
Total net income-8 M-9 M-23 M-11 M-12 M-24 M-21 M-34 M-76 M-65 M
Total ordinary shares83 M83 M83 M83 M83 M83 M83 M83 M83 M83 M
Total revenues16 M18 M50 M61 M68 M69 M105 M139 M70 M59 M
TotalExpenses37 M-67 M-87 M47 M81 M93 M127 M170 M125 M118 M
TotalRevenue39 M49 M50 M61 M68 M69 M105 M139 M70 M59 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader